Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Digital Therapeutics For Fibromyalgia Market Size, Value And Growth Trajectory Through 2030
The digital therapeutics for fibromyalgia market size has experienced significant expansion in recent years. It is anticipated to expand from $1.19 billion in 2025 to $1.44 billion in 2026, achieving a compound annual growth rate (CAGR) of 21.1%. The market’s growth during the preceding period is attributable to heightened awareness of fibromyalgia management requirements, increasing adoption of digital health solutions, expanded smartphone penetration within healthcare, the spread of telehealth services, and the constraints of traditional pain management methods.
The digital therapeutics for fibromyalgia market size is projected to experience substantial growth over the next few years. It is expected to expand to $3.07 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 20.8%. This expansion in the projected period is driven by factors such as the increasing demand for personalized chronic pain management, the rising integration of AI-driven therapy optimization, the broadening of remote care reimbursement models, an amplified focus on data-driven treatment personalization, and enhanced collaboration between clinicians and digital health providers. Prominent trends for the forecast period include a growing adoption of mobile therapies for symptom tracking, the increasing utilization of personalized digital care plans, the expanding integration of wearables with therapeutic platforms, the widening scope of remote patient monitoring programs, and a strengthened emphasis on patient engagement and adherence.
Get A Free Sample Report With In-Depth Market Insights:
Digital Therapeutics For Fibromyalgia Market Expansion Drivers: What’s Shaping Future Growth?
Increased understanding of digital health tools is anticipated to fuel the expansion of the digital therapeutics for fibromyalgia market in the future. These solutions encompass software-driven tools and services, including patient applications, patient portals, and virtual care platforms, designed to provide information, monitoring, and therapeutic interventions via digital channels. This rising recognition of digital health solutions stems from government-supported initiatives and the broad uptake of official health applications, which make accessing care online a common practice. Digital therapeutics for fibromyalgia capitalize on this heightened awareness by engaging patients through these familiar digital avenues, simplifying the process of starting and consistently using app-based cognitive behavioral therapy, pacing, and sleep programs, all while allowing for clinician supervision. As an illustration, in December 2023, data from the National Health Service, a UK-based government department, indicated that digital health app users totaled 33.6 million, an increase from 16.8 million in 2022. Furthermore, monthly logins saw a 54% jump, moving from 16.8 million to 25.8 million. Consequently, the expanding understanding of digital health solutions is propelling the digital therapeutics for fibromyalgia market.
Digital Therapeutics For Fibromyalgia Market Segments: Where Is Growth Concentrated?
The digital therapeutics for fibromyalgia market covered in this report is segmented –
1) By Product Type: Software Applications, Devices, Platforms
2) By Therapy Area: Cognitive Behavioral Therapy, Mindfulness-Based Interventions, Pain Management, Other Therapy Types
3) By Distribution Channel: Online, Offline
4) By Application: Chronic Pain Management, Sleep Disorders, Fatigue Management, Other Applications
5) By End-User: Hospitals, Clinics, Homecare, Other End-Users
Subsegments:
1) By Software Applications: Mobile Applications, Web-Based Applications, Cloud-Based Applications, Virtual Reality Applications
2) By Devices: Wearable Devices, Handheld Devices, Smart Monitoring Devices, Connected Therapeutics Devices
3) By Platforms: Telehealth Platforms, Remote Monitoring Platforms, Patient Engagement Platforms, Data Analytics Platforms
Digital Therapeutics For Fibromyalgia Market Strategic Trends: What Defines The Next Growth Phase?
Major companies in the digital therapeutics for fibromyalgia market are prioritizing technological advancements, such as computerized behavioral therapy devices, to offer evidence-based interventions. These interventions aim to improve pain management, reduce fatigue, enhance sleep quality, and support mental health, all delivered via scalable, patient-centric digital platforms. A computerized behavioral therapy device is a software-based digital platform or application that provides structured, evidence-based cognitive or behavioral therapy interventions to patients remotely, often utilizing interactive modules, exercises, and real-time feedback to manage symptoms of conditions like fibromyalgia. For instance, in May 2023, Swing Therapeutics, Inc., a US-based biopharmaceutical company, launched Stanza following U.S. FDA De Novo marketing authorization (DEN220083). It provides a 12-week, self-guided acceptance and commitment therapy (ACT) program for fibromyalgia, with a randomized controlled trial reported in the lancet showing significant clinical improvements. This therapy is delivered through smartphones (iOS or Android), offering patients convenient, in-app, at-home treatment.
Digital Therapeutics For Fibromyalgia Market Key Participants And Competitive Landscape
Major companies operating in the digital therapeutics for fibromyalgia market are Grünenthal GmbH, Hinge Health Inc., DarioHealth Corp., Kaia Health, CogniFit Inc., Big Health Ltd., Remedee Labs, HelloBetter GmbH, AppliedVR Inc., PainDrainer, Swing Therapeutics Inc., Fern Health Inc., JOGO Health Inc., LIN Health Inc., MoreGoodDays, Happify Health Inc., Click Therapeutics Inc., Wellthy Therapeutics Pvt. Ltd., FlexifyMe, SleepioRx
View The Full Digital Therapeutics For Fibromyalgia Market Report:
Digital Therapeutics For Fibromyalgia Market Geographic Spread And Regional Opportunities
North America was the largest region in the digital therapeutics for fibromyalgia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics for fibromyalgia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
